SCHEMBL2495976

SCHEMBL2495976

N[Pt]N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22028253 0.89
SCHEMBL4323422 0.61
SCHEMBL8720895 0.50
SCHEMBL26688313 0.50
SCHEMBL2701509 0.50
SCHEMBL31091799 0.50
Iodide SCHEMBL619550 0.35
Hydrazine SCHEMBL2463370 0.35
SCHEMBL35987 0.35
SCHEMBL2774955 0.35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230398077-A1 SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-12-14 US claimed
EP-4237091-A1 A SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-09-06 EP claimed
WO-2022094132-A1 A SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-05-05 WO claimed
CN-110339207-A The prophylactic and/or therapeutic agent of the side effect of anticancer agent 思佰益药业股份有限公司 2019-10-18 CN claimed
CN-108130566-B Electroplate liquid and its electro-plating method for nickel base superalloy electroplating surface platinum layer 西北有色金属研究院 2019-08-27 CN claimed
CN-108130566-A For the electroplate liquid and its electro-plating method of nickel base superalloy electroplating surface platinum layer 西北有色金属研究院 2018-06-08 CN claimed
CN-105612644-B Electrode catalyst for fuel cell and its manufacture method 株式会社科特拉 2017-12-19 CN claimed
EP-2913335-B1 ANTI-TUMOR BIVALENT PLATINUM COMPLEX AND PREPARATION METHOD FOR COMPLEX AND LIGAND OF COMPLEX UNIV SOUTHEAST (CN) 2017-03-29 EP claimed
WO-2006084248-A2 COMPOSITIONS COMPRISING A PLATINUM COMPLEX, LIPID, AND SURFACTANT ANTIGENICS, INC. (US) 2006-08-10 WO claimed
US-6221906-B1 ANTICANCER AGENTS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2001-04-24 US claimed
EP-1082331-A1 PLATINUM COMPLEX CONJUGATED TO CYCLOTRIPHOSPHAZENE, ITS PREPARATION, AND ANTICANCER AGENT COMPRISING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2001-03-14 EP claimed
WO-2000058321-A1 PLATINUM COMPLEX CONJUGATED TO CYCLOTRIPHOSPHAZENE, ITS PREPARATION, AND ANTICANCER AGENT COMPRISING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2000-10-05 WO claimed
US-4994591-A Antitumor, anticarcinogenic agents THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NY (US) 1991-02-19 US claimed
US-4209384-A CATALYSIS UOP INC. (US) 1980-06-24 US claimed
US-20260104418-A1 CLAUDIN18 ANTIBODIES AND METHODS OF TREATING CANCER UNIV CALIFORNIA (US) 2026-04-16 US disclosed
US-12599650-B2 Inhibition of SIRP-gamma for cancer treatment AMGEN INC. (US) 2026-04-14 US disclosed
US-20260035477-A1 ANTI-PODXL ANTIBODIES FOR INHIBITING CTC CLUSTERING UNIV NORTHWESTERN (US) 2026-02-05 US disclosed
EP-0099133-B1 ANTI-CANCER DRUGS COMPRISING PLATINUM COMPLEXES YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD. (IL) 1988-11-23 EP disclosed
EP-0099133-A2 Anti-cancer drugs comprising platinum complexes YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD. (IL) 1984-01-25 EP disclosed
US-4209384-A CATALYSIS UOP INC. (US) 1980-06-24 US disclosed